Previous close | 5.0100 |
Open | 4.8000 |
Bid | 0.0000 x 800 |
Ask | 0.0000 x 1800 |
Day's range | 4.8000 - 4.9700 |
52-week range | 4.2400 - 8.7000 |
Volume | |
Avg. volume | 17,704 |
Market cap | 77.894M |
Beta (5Y monthly) | 1.49 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0670 |
Earnings date | 27 July 2022 - 01 Aug 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Investors who take an interest in Ultralife Corporation ( NASDAQ:ULBI ) should definitely note that the Independent...
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
NEWARK, N.Y., April 28, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported an operating loss of $0.3 million on revenue of $30.4 million for the first quarter ended March 31, 2022. For the first quarter of 2021, the Company reported operating income of $1.0 million on revenue of $26.0 million. “Strong order flow in commercial end-markets, particularly medical and oil & gas, along with a lift from recently acquired Excell Battery Group (“Excell”), more than offset supply chain